- Prescribing Advice for GPs - https://www.prescriber.org.uk -

Quetiapine SPC update

The manufacturer of quetiapine (Seroquel®) has written to healthcare professionals advising of an update to the summary of product characteristics for both the standard and prolonged release tablets.

The letter advises that the update to the special warnings and precautions section includes advice on:

Action: The metabolic risks posed by second generation (atypical) antipsychotics are well known. This update reminds clinicians of the need to monitor for these effects and intervene where appropriate.